Roadmaps to Regulation: Cannabis

On 26 May 2016, the New Psychoactive Substances Act passed into UK law, rendering it illegal to buy, sell or supply any substance deemed to have psychoactive properties.

But what will happen to the public appetite for “legal highs,” and what will happen to the drugs themselves?

To mark the day, Amanda Feilding and the Beckley Foundation have released this chapter on NPS from our forthcoming report, “Roadmaps to Regulation: Cannabis, Psychedelics, MDMA and NPS.” The chapter explains the medical and social fallacies of applying a blanket ban to this vast array of chemically dissimilar substances, and strategises how we could legally regulate the unquellable market for NPS.

“Who would want N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide when they could legally purchase cannabis?”

Amanda Feilding